VC
Value Add VC
⚡HomePulse⚡Helpful Apps📝Blog🤝Partner
Illustration for: BofA's Sell Signal Hits Highest Level Since 2021
Value Add VC/Pulse/IPOBRIEF

BofA's Sell Signal Hits Highest Level Since 2021

Bank of America's Bull & Bear sentiment indicator jumped to 9.7 -- its highest reading since 2021 and above the firm's own 8.0 sell-signal threshold -- even as the S&P 500 and Nasdaq both rallied Friday on weak jobs data.

By the Numbers

9.7
Bull & Bear reading
8.0
Sell-signal threshold
9.4
Prior reading
$32.9B
Weekly equity inflows
TC
Trace Cohen
Early-stage VC & angel · Founder, New York Venture Partners
August 7, 2026
1 min read
ShareXLinkedInEmail
TC

The VC Read · Trace's Take

Trace Cohen

BofA's indicator has been directionally right before, but 'above 8.0' has triggered false-alarm sell signals in past cycles too -- the useful read isn't 'sell everything now,' it's 'the market has very little room left to absorb bad news without a sharp reaction.' For any GP marking up a portfolio company against public comps right now, this is the moment to stress-test those comps against a 15-20% multiple compression, not just extrapolate today's multiples forward.

Analysis

Bank of America's Bull & Bear Indicator, the firm's contrarian gauge of investor positioning, rose to 9.7 this week from 9.4, its highest reading since 2021 and above the 8.0 level BofA defines as a sell signal, according to CNBC and Bloomberg. The gauge is built from equity fund flows, credit spreads and global stock-market breadth; strong high-yield bond inflows and tighter spreads on global high-yield and Tier 1 bonds drove this week's jump.

Weekly flows into equities totaled $32.9 billion, split between $40.1 billion into ETFs and $7.2 billion of outflows from mutual funds -- a rotation pattern BofA reads as retail and systematic money piling in while some active managers trim. BofA's own recommendation in response is to reduce exposure to risk assets and rotate into defensives: consumer staples, REITs, small caps, biotech and the US dollar.

“BofA's own recommendation in response is to reduce exposure to risk assets and rotate into defensives: consumer staples, REITs, small caps, biotech and the US dollar.”

The reading landed the same day the S&P 500 and Nasdaq both rallied on a weaker-than-expected July jobs report, and the same week Atlassian and Twilio both posted double-digit earnings-driven stock jumps -- meaning the market's most extreme bullish sentiment reading in five years arrived precisely when there was the most genuinely good news to justify it, not despite an absence of it.

ShareXLinkedInEmail

Reported by CNBC · First reported by Bloomberg · Analysis by Value Add Pulse.

← Back to Pulse

THE WIRE in your inbox— Tech, startup & VC news with Trace's take. Free, no spam.

Read Next

IPO· Aug 7, 2026

Wall Street Rallies on Weak Jobs Data as Software Earnings Beat

Illustration for: Wall Street Rallies on Weak Jobs Data as Software Earnings Beat
IPO

Wall Street Rallies on Weak Jobs Data as Software Earnings Beat

A weak July jobs report sent stocks to a broad rally on rate-cut bets, with Atlassian and Twilio posting blowout earnings beats -- even as Bank of America's own sentiment gauge hit its most bullish reading since 2021.

IPO· Aug 7, 2026

Atlassian Stock Jumps 36% on Cloud, AI Earnings Beat

Illustration for: Atlassian Stock Jumps 36% on Cloud, AI Earnings Beat
IPO+35.6% stock move

Atlassian Stock Jumps 36% on Cloud, AI Earnings Beat

Atlassian shares surged as much as 35.6% after fiscal Q4 revenue beat estimates by $100M+ on 31% cloud growth, with co-founder Mike Cannon-Brookes pledging to personally buy up to $250M of stock.

IPO· Aug 7, 2026

BlossomHill Prices Upsized $150M IPO, Debuts on Nasdaq

Illustration for: BlossomHill Prices Upsized $150M IPO, Debuts on Nasdaq
IPO$150M IPO

BlossomHill Prices Upsized $150M IPO, Debuts on Nasdaq

BlossomHill Therapeutics priced an upsized IPO at $16 a share for $150M and began trading on Nasdaq under BLSM, more than 50% above the $100M target Pulse flagged when the company first filed.

@Trace_Cohen·t@nyvp.com